Botulinum toxin treatment for spasticity and essential tremor
HAYES, Inc.
Record ID 32006000984
English
Authors' objectives:
Botulinum toxin (BTX) type A and B are neurotoxins produced by the bacterium Clostridium (C.) botulinum, which block the release of the neurotransmitter acethylcholine at the neuromuscular junction, thereby interfering with nerve transmission and blocking subsequent muscle contraction. BTX is used to reduce excessive muscle contraction or spasm associated with a variety of movement disorders that include spasticity and/or tremors.
Authors' methods:
Review
Details
Project Status:
Completed
URL for project:
http://www.hayesinc.com/
Year Published:
2006
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
United States
MeSH Terms
- Botulinum Toxins
- Treatment Outcome
- Essential Tremor
- Muscle Spasticity
- Neuromuscular Agents
- Tremor
Contact
Organisation Name:
HAYES, Inc.
Contact Address:
157 S. Broad Street, Suite 200, Lansdale, PA 19446, USA. Tel: 215 855 0615; Fax: 215 855 5218
Contact Name:
saleinfo@hayesinc.com
Contact Email:
saleinfo@hayesinc.com
Copyright:
HAYES, Inc.
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.